Navigation Links
BioMarin to Present at the Oppenheimer Healthcare Conference
Date:10/27/2009

NOVATO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) today announced that Hank Fuchs, M.D., Chief Medical Officer of BioMarin, will present a company update at the Oppenheimer Healthcare Conference in New York City on Tuesday, November 3, 2009 at 1:35 p.m. ET.

Interested parties may access a live audio webcast of the conference call via the investor section of the BioMarin website, www.BMRN.com. A replay of the call will be archived on the site for one week following the call.

About BioMarin

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany. Other product candidates include PEG-PAL (PEGylated recombinant phenylalanine ammonia lyase), which is in Phase II clinical development for the treatment of PKU and GALNS (N-acetylgalactosamine 6-sulfatase), which is currently in Phase I/II clinical development for the treatment of MPS IVA. For additional information, please visit www.BMRN.com. Information on BioMarin's website is not incorporated by reference into this press release.

BioMarin®, Naglazyme® and Kuvan® are registered trademarks of BioMarin
'/>"/>

SOURCE BioMarin Pharmaceutical Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. BioMarin Acquires Huxley Pharmaceuticals, Inc.
2. BioMarin Initiates Phase 2 Clinical Study of PEG-PAL in PKU
3. BioMarin Initiates Phase 1/2 Clinical Trial for GALNS for Morquio A Syndrome
4. BioMarin Announces Positive Results From Phase 2A Clinical Study of 6R-BH4 in Sickle Cell Disease
5. BioMarin Initiates Phase 1 Clinical Study of PEG-PAL in PKU
6. BioMarin Announces FDA Approval for Kuvan
7. BioMarin Partner AnGes MG, Inc. Submits BLA to Japanese Ministry of Health
8. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
9. Phase 2 Data From Oral NKTR-118 Presented at American College of Gastroenterology in San Diego
10. STAAR Surgical to Present at the 20th Annual Oppenheimer Healthcare Conference in New York
11. Regeneron Announces Presentation at the 18th Annual Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... June 30, 2015  The MEDevice San Diego Conference, ... an event dedicated to bringing medtech professionals together for ... topics affecting the industry today. This year,s conference will ... and opportunities facing today,s medtech professional in a fun, ... register for MEDevice San Diego, please visit: MEDeviceSD.com. ...
(Date:6/30/2015)... June 30, 2015 Velos, Inc., the pioneering ... to grow and add customers who receive Clinical and ... 62 CTSAs awarded by the National Institutes of Health ... This is among the largest such market shares in ... the CTSA community keeps growing as a result of ...
(Date:6/30/2015)... Nortek Security & Control LLC, a ... a leader in the residential and commercial security ... mobile personal emergency response system (mPERS) and telehealth ... Headquartered in Seattle ... products and cloud-based software platforms that enable providers ...
Breaking Medicine Technology:MEDevice San Diego 2015 Attracts High-Tech Medical Industry 2Velos continues adding CTSA customers - 40% now use Velos products 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 2Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 3Nortek Security & Control Acquires Health and Wellness Technology Business from Numera 4
... Misonix, Inc. (Nasdaq: MSON ), a developer ... which worldwide is used for acute health conditions, today ... year ending June 30, 2010.  Michael A. McManus, Jr., ... VP and Chief Financial Officer, will host a conference ...
... YORK, Sept. 28 Reportlinker.com announces that a new ... Global In Vitro Diagnostics (IVD) Market Report: ... The global IVD market has been experiencing ... has been growing awareness about health and prevention of ...
Cached Medicine Technology:Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 2Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 3Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 4Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 5Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 6Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 7Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 8Misonix Reports Fourth Quarter and Fiscal Year 2010 Financial Results 9Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 2Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 3Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 4Reportlinker Adds Global In Vitro Diagnostics (IVD) Market Report: 2010 Edition 5
(Date:6/30/2015)... , ... June 30, 2015 , ... Broadway by the ... features multiple patient and family member testimonials. Medicare rated the care center as a ... to use the video to give future patients a firsthand look at the facility’s ...
(Date:6/30/2015)... ... June 30, 2015 , ... After many ... , finally its here, http://www.express-glasses.com is proud to announce its collaboration ... ask about shipping with DHL Express when calling or visiting the express glasses ...
(Date:6/30/2015)... ... June 30, 2015 , ... The progress of more ... litigation now underway in the U.S. District Court, Eastern District of Louisiana, will ... the Court’s calendar, that conference has now been scheduled for July 9th, at ...
(Date:6/30/2015)... ... June 30, 2015 , ... Rocky Mountain Oils, a leading non-MLM supplier ... added a new CEO, Mr. Darold Francis. The changes will help enhance the company’s ... that customers have come to know and respect for over eight years. , “I ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... Eleven physicians from Allied’s Fullerton division volunteered to help provide free outpatient procedures ... Saturday, March 21, at St. Jude Medical Center. , The event was ...
Breaking Medicine News(10 mins):Health News:Broadway by the Sea Video Promotes Top Quality Service 2Health News:Eyeglasses Online - Express Glasses Announcing New International Shipping Using DHL 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:Rocky Mountain Oils Adds New CEO, Announces Relocation of Operations to Orem, Utah 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 2Health News:Allied Anesthesia Physicians Volunteer to Help Orange County’s Uninsured During Annual Super Surgery Saturday 3
... Aug. 24, 2011 Exercise can be as ... half of depressed patients whose condition have not been ... Medical Center scientists involved in the investigation, recently published ... moderate and intense levels of daily exercise can work ...
... , TUESDAY, Aug. 23 (HealthDay News) -- Women at ... likely to stick with a drug regimen meant to prevent cancer, ... tamoxifen by 11,000 women with a high risk of breast cancer ... Bowel Project,s Breast Cancer Prevention Trial. Heavy drinkers (more than ...
... TUESDAY, Aug. 23 (HealthDay News) -- Women suffering from heart ... in hospitals that follow American Heart Association guidelines, , according ... heart failure were generally older than men (average age 74 ... the hospital. "We,ve previously had little data on ...
... (IBD), which affects more than 1 million patients in ... by environmental factors, such as bacteria, in people genetically ... the lining of the colon, is one such condition. ... prompted by different cytokines small signaling proteins secreted ...
... in a new study a different approach to predict ... other similar chemicals. For many chemicals in ... to understand all of the effects on the environment ... Union enacted the REACH regulation, which places greater responsibility ...
... For men with erectile dysfunction (ED), 65 percent are ... problems with ejaculation, according to new research led by ... study followed 12,130 men with mild to severe ED ... dysfunction. Results are published in today,s edition of the ...
Cached Medicine News:Health News:Exercise can substitute effectively as second 'medication' for people with depression 2Health News:Women Who Drink, Smoke Are Less Likely to Stick With Tamoxifen 2Health News:Women With Heart Failure Treated as Well as Men: Study 2Health News:Novel cytokine protects mice from colitis 2Health News:Scientists develop new approaches to predict the environmental safety of chemicals 2Health News:When erectile dysfunction isn't whole story 2Health News:When erectile dysfunction isn't whole story 3
Sony DVD Recorder for recording and playback of DVD video discs to complement DP micro video cameras....
... consists of 2-piece body, one is CHU (Camera ... built-in Peltier cooling devices, the other is CCU ... CCU incorporates IEEE1394 interface for direct connection with ... slot for storing images into memory stick or ...
The TRIstar II is a highly developed 3-chip video camera for endoscopic applications. Superior image quality and outstanding colour reproduction meets professional requirements....
For continuous intracranial monitoring of pressure, oxygen and temperature of the brain...
Medicine Products: